相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Histamine-4 receptor antagonist ameliorates Parkinson-like pathology in the striatum
Qiuyuan Fang et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
Conditional Deletions of Hdc Confirm Roles of Histamine in Anaphylaxis and Circadian Activity but Not in Autoimmune Encephalomyelitis
Francoise Morin et al.
JOURNAL OF IMMUNOLOGY (2021)
Histamine pharmacology: from Sir Henry Dale to the 21st century
Ekaterini Tiligada et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
The zebrafish histamine H3 receptor modulates aggression, neural activity and forebrain functional connectivity
Florian Reichmann et al.
ACTA PHYSIOLOGICA (2020)
Histaminergic Control of Corticostriatal Synaptic Plasticity during Early Postnatal Development
Sungwon Han et al.
JOURNAL OF NEUROSCIENCE (2020)
Adult male patient with severe intellectual disability caused by a homozygous mutation in the HNMT gene
Willem M. A. Verhoeven et al.
BMJ CASE REPORTS (2020)
Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment
Claudio L. A. Bassetti et al.
NATURE REVIEWS NEUROLOGY (2019)
Histamine-4 receptor antagonist JNJ7777120 inhibits pro-inflammatory microglia and prevents the progression of Parkinson-like pathology and behaviour in a rat model
Pei Zhou et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
The neurobiological basis of narcolepsy
Carrie E. Mahoney et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial
Zoltan Szakacs et al.
LANCET NEUROLOGY (2017)
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier et al.
NATURE REVIEWS NEUROSCIENCE (2017)
The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use
Marta Kollb-Sielecka et al.
SLEEP MEDICINE (2017)
Diurnal fluctuation in the number of hypocretin/orexin and histamine producing: Implication for understanding and treating neuronal loss
Ronald McGregor et al.
PLOS ONE (2017)
Histamine N-methyltransferase regulates aggression and the sleep-wake cycle
Fumito Naganuma et al.
SCIENTIFIC REPORTS (2017)
Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases
Bassem Sadek et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation
Sandra M. Rocha et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Mutations in the histamine N-methyltransferase gene, HNMT, are associated with nonsyndromic autosomal recessive intellectual disability
Abolfazl Heidari et al.
HUMAN MOLECULAR GENETICS (2015)
Interactions of the histamine and hypocretin systems in CNS disorders
Ling Shan et al.
NATURE REVIEWS NEUROLOGY (2015)
Doxepin and diphenhydramine increased non-rapid eye movement sleep through blockade of histamine H1 receptors
Yi-Qun Wang et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
A Phase II study of a histamine H3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy
L. Fredrik Jarskog et al.
SCHIZOPHRENIA RESEARCH (2015)
Doxepin for insomnia: A systematic review of randomized placebo-controlled trials
Wing-Fai Yeung et al.
SLEEP MEDICINE REVIEWS (2015)
Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Momoko Kubo et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
Pertti Panula et al.
PHARMACOLOGICAL REVIEWS (2015)
A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H-3 Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer's Disease
Richard A. Grove et al.
CURRENT ALZHEIMER RESEARCH (2014)
Circadian Factor BMAL1 in Histaminergic Neurons Regulates Sleep Architecture
Xiao Yu et al.
CURRENT BIOLOGY (2014)
Conditional Ablation of Orexin/Hypocretin Neurons: A New Mouse Model for the Study of Narcolepsy and Orexin System Function
Sawako Tabuchi et al.
JOURNAL OF NEUROSCIENCE (2014)
A Randomized Trial of the Efficacy and Safety of the H3 Antagonist ABT-288 in Cognitive Impairment Associated With Schizophrenia
George M. Haig et al.
SCHIZOPHRENIA BULLETIN (2014)
Histamine: a new immunomodulatory player in the neuron-glia crosstalk
Sandra M. Rocha et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Increase of Histaminergic Tuberomammillary Neurons in Narcolepsy
Philipp O. Valko et al.
ANNALS OF NEUROLOGY (2013)
Greatly Increased Numbers of Histamine Cells in Human Narcolepsy with Cataplexy
Joshi John et al.
ANNALS OF NEUROLOGY (2013)
Neuronal histaminergic system in aging and age-related neurodegenerative
Ling Shan et al.
EXPERIMENTAL GERONTOLOGY (2013)
A Randomized Clinical Trial of Histamine 2 Receptor Antagonism in Treatment-Resistant Schizophrenia
Katarina Meskanen et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
Yves Dauvilliers et al.
LANCET NEUROLOGY (2013)
The histaminergic network in the brain: basic organization and role in disease
Pertti Panula et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Review of the histamine system and the clinical effects of H1 antagonists: Basis for a new model for understanding the effects of insomnia medications
Andrew D. Krystal et al.
SLEEP MEDICINE REVIEWS (2013)
Pilot Randomized Controlled Study of a Histamine Receptor Inverse Agonist in the Symptomatic Treatment of AD
Michael Egan et al.
CURRENT ALZHEIMER RESEARCH (2012)
Functional implications of hypothalamic neurogenesis in the adult mammalian brain
Daniel A. Lee et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2012)
Activity-dependent neurotransmitter respecification
Nicholas C. Spitzer
NATURE REVIEWS NEUROSCIENCE (2012)
Neuronal histamine production remains unaltered in Parkinson's disease despite the accumulation of Lewy bodies and Lewy neurites in the tuberomamillary nucleus
Ling Shan et al.
NEUROBIOLOGY OF AGING (2012)
Alterations in the histaminergic system in Alzheimer's disease: a postmortem study
Ling Shan et al.
NEUROBIOLOGY OF AGING (2012)
Alterations in the histaminergic system in the substantia nigra and striatum of Parkinson's patients: a postmortem study
Ling Shan et al.
NEUROBIOLOGY OF AGING (2012)
Diurnal Fluctuation in Histidine Decarboxylase Expression, the Rate Limiting Enzyme for Histamine Production, and Its Disorder in Neurodegenerative Diseases
Ling Shan et al.
SLEEP (2012)
Normal Cerebrospinal Fluid Histamine and tele-Methylhistamine Levels in Hypersomnia Conditions
Yves Dauvilliers et al.
SLEEP (2012)
Functional Increase of Brain Histaminergic Signaling in Huntington's Disease
Daniel J. van Wamelen et al.
BRAIN PATHOLOGY (2011)
Histamine receptors in the CNS as targets for therapeutic intervention
Maria Beatrice Passani et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Emerging new sites for adult neurogenesis in the mammalian brain: a comparative study between the hypothalamus and the classical neurogenic zones
Martine Migaud et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin
Claudio L. Bassetti et al.
JOURNAL OF SLEEP RESEARCH (2010)
Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia
Andrew D. Krystal et al.
SLEEP (2010)
Efficacy and safety of doxepin 6 mg in a model of transient insomnia
Thomas Roth et al.
SLEEP MEDICINE (2010)
Histamine, antihistamines, and the central nervous system
Philip Lieberman
ALLERGY AND ASTHMA PROCEEDINGS (2009)
Decreased CSF Histamine in Narcolepsy With and Without Low CSF Hypocretin-1 in Comparison to Healthy Controls
Seiji Nishino et al.
SLEEP (2009)
A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: The empirical basis for US clinical practice
Andrew D. Krystal
SLEEP MEDICINE REVIEWS (2009)
The histamine H1-receptor mediates the motivational effects of novelty
A. Zlomuzica et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
An inverse agonist of the histamine H3 receptor improves wakefulness in narcolepsy:: Studies in orexin-/- mice and patients
Jian-Sheng Lin et al.
NEUROBIOLOGY OF DISEASE (2008)
Histamine in the nervous system
Helmut L. Haas et al.
PHYSIOLOGICAL REVIEWS (2008)
Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats
Chun-Qing Liu et al.
NEUROPHARMACOLOGY (2007)
Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia
Thomas Roth et al.
SLEEP (2007)
Hypocretin (orexin) cell loss in Parkinson's disease
Thomas C. Thannickal et al.
BRAIN (2007)
Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors
Hongmei Dai et al.
NEUROSCIENCE RESEARCH (2007)
The physiological and pathophysiological roles of neuronal histamine: An insight from human positron emission tomography studies
Kazuhiko Yanai et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Decreased histamine H1 receptor binding in the brain of depressed patients
M Kano et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Circadian rhythms in behavior and clock gene expressions in the brain of mice lacking histidine decarboxylase
H Abe et al.
MOLECULAR BRAIN RESEARCH (2004)
Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy
JO Rinne et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Where does Parkinson disease pathology begin in the brain?
K Del Tredici et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Doxepin in the treatment of primary insomnia:: A placebo-controlled, double-blind, polysomnographic study
G Hajak et al.
JOURNAL OF CLINICAL PSYCHIATRY (2001)
Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity
J Hara et al.
NEURON (2001)
Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on the posterior hypothalamus and histaminergic neurons
JS Lin
SLEEP MEDICINE REVIEWS (2000)
Histamine infusion induces a selective dopaminergic neuronal death along with an inflammatory reaction in rat substantia nigra
ML Vizuete et al.
JOURNAL OF NEUROCHEMISTRY (2000)
An altered histaminergic innervation of the substantia nigra in Parkinson's disease
OV Anichtchik et al.
EXPERIMENTAL NEUROLOGY (2000)
Reduced number of hypocretin neurons in human narcolepsy
TC Thannickal et al.
NEURON (2000)
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
C Peyron et al.
NATURE MEDICINE (2000)
Histamine H-1 receptors in patients with Alzheimer'sdisease assessed by positron emission tomography
M Higuchi et al.
NEUROSCIENCE (2000)
Histamine H-2 receptor gene variants: lack of association with schizophrenia
C Ito et al.
MOLECULAR PSYCHIATRY (2000)
分享论文
